Offer - Urjas Oil for just ₹ 1 X
Optichlor P is a prescription medicine that is available as a Drops. Optichlor P also has some secondary and off-label uses. These are listed below.
The correct dosage of Optichlor P depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Optichlor P have been listed ahead. Usually, these side effects of Optichlor P go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Optichlor P has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Optichlor P's effects on the liver, heart and kidney are discussed below in the Optichlor P related warnings section.
Optichlor P can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Optichlor P in conditions like Kidney Disease, Kidney Disease, Liver Disease. Other conditions have been mentioned below in the Optichlor P contraindications section.
Drug interactions for Optichlor P have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Optichlor P is safe while driving, and is is addictive in nature.
Optichlor P is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Optichlor P safe for pregnant women?
Optichlor P can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Optichlor P safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Optichlor P. So it is adviced to consult the doctor before using it.
What is the effect of Optichlor P on the Kidneys?
Optichlor P rarely harms the kidneys.
What is the effect of Optichlor P on the Liver?
You may experience side effects on your liver after taking Optichlor P. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Optichlor P on the Heart?
There may be an adverse effect on the heart after taking Optichlor P. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Optichlor P should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Optichlor P unless your doctor advises you to do so -
Is this Optichlor P habit forming or addictive?
Optichlor P does not cause addiction.
Interaction between Food and Optichlor P
Taking Optichlor P with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Optichlor P
It is difficult to say anything about the effect of Optichlor P and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Polymyxin B
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 759
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742